These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1182748

  • 1. [Activity of 2,4 dinitrochlorbenzene skin tests during the course of immunotherapy of malignant melanomas].
    Richter J, Duchková H, Kubíková M.
    Cas Lek Cesk; 1975 Sep 26; 114(39):1201-3. PubMed ID: 1182748
    [No Abstract] [Full Text] [Related]

  • 2. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
    Trapeznikov NN, Iavorskiĭ VV, Kadagidze ZG, Malaev SG, Kupin VI.
    Vopr Onkol; 1977 Sep 26; 23(8):27-33. PubMed ID: 906404
    [Abstract] [Full Text] [Related]

  • 3. [Immunotherapy of malignant melanomas].
    Macher E.
    Haematol Blood Transfus; 1978 Sep 26; 21():285-91. PubMed ID: 738638
    [No Abstract] [Full Text] [Related]

  • 4. Immunologic defects in melanoma patients: lack of effect of BCG therapy.
    Gersten MJ, Hadden EM, Kaplan MH, Pinsky CM, Armstrong D, Hadden JW.
    Clin Bull; 1977 Sep 26; 7(2):63-9. PubMed ID: 902403
    [No Abstract] [Full Text] [Related]

  • 5. [Active non-specific immunotherapy in the treatment of colonic and rectal cancer].
    dos Reis Neto JA, Quilici FA, Pedro RJ.
    AMB Rev Assoc Med Bras; 1980 Oct 26; 26(10):324-7. PubMed ID: 6972054
    [No Abstract] [Full Text] [Related]

  • 6. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
    Knopf B, Wätzig V, Knöll B.
    Arch Geschwulstforsch; 1978 Oct 26; 48(8):722-8. PubMed ID: 753194
    [Abstract] [Full Text] [Related]

  • 7. [Use of immunotherapy in the treatment of malignant melanoma of the skin].
    Kristensen E.
    Ugeskr Laeger; 1976 Feb 16; 138(8):468-73. PubMed ID: 1258215
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of malignant melanoma by intratumoral injection of BCG.
    Pinsky CM, Hirshaut Y, Oettgen HF.
    Natl Cancer Inst Monogr; 1973 Dec 16; 39():225-8. PubMed ID: 4595322
    [No Abstract] [Full Text] [Related]

  • 9. [Nonspecific immunostimulation and immunochemotherapy of melanomas].
    Israël L.
    Rev Prat; 1975 Nov 16; 25(51):4063-4, 4067-8. PubMed ID: 1209147
    [No Abstract] [Full Text] [Related]

  • 10. Adjuvant combination immunotherapy (BCG and levamisole) in malignant melanoma.
    Dandapat MC, Mohapatra SK, Patra SK.
    Indian J Cancer; 1985 Jun 16; 22(2):100-7. PubMed ID: 3842124
    [No Abstract] [Full Text] [Related]

  • 11. [Intrafocal BCG therapy of metastasizing malignant melanoma].
    Kunze J, Lesch R, Plagwitz R, Hagedorn M.
    Hautarzt; 1978 Nov 16; 29(11):597-600. PubMed ID: 721465
    [Abstract] [Full Text] [Related]

  • 12. [Clinical administration of BCG-immunotherapy in malignant melanoma (author's transl)].
    Wätzig V, Knopf B.
    Arch Geschwulstforsch; 1979 Nov 16; 49(2):140-5. PubMed ID: 475550
    [Abstract] [Full Text] [Related]

  • 13. [Malignant melanoma of the skin. Current experiences in diagnosis, histoprognostic classification and therapy].
    Romano S, De Marini F, Filippi B.
    Minerva Chir; 1979 Nov 30; 34(22):1523-5. PubMed ID: 548830
    [No Abstract] [Full Text] [Related]

  • 14. BCG in cancer therapy: theoretical bases of immunotherapy.
    Dodd MJ.
    Am J Nurs; 1979 Feb 30; 79(2):310-4. PubMed ID: 311587
    [No Abstract] [Full Text] [Related]

  • 15. [Immunotherapy of melanoma (proceedings)].
    Bolund C.
    Lakartidningen; 1978 Dec 06; 75(49):4598. PubMed ID: 723350
    [No Abstract] [Full Text] [Related]

  • 16. Results of adjuvant BCG immunotherapy in malignant melanoma.
    Wätzig V, Knopf B.
    Arch Geschwulstforsch; 1981 Dec 06; 51(6):493-6. PubMed ID: 7332442
    [Abstract] [Full Text] [Related]

  • 17. [Immunotherapy of malignant melanoma].
    Adler A.
    Harefuah; 1986 Jul 06; 111(1-2):11-7. PubMed ID: 3781371
    [No Abstract] [Full Text] [Related]

  • 18. [Possibilities of an immunotherapy of malignant skin tumors with particular consideration of malignant melanomas (author's transl)].
    Schöpf E.
    Ther Umsch; 1976 Aug 06; 33(8):538-42. PubMed ID: 1006610
    [No Abstract] [Full Text] [Related]

  • 19. [Immunotherapy with BCG as coadjuvant in the management of malignant melanomas].
    Céspedes de Gómez MM, Aguilar Velázquez G, Valles de Cortés Y.
    Alergia; 1980 Apr 06; 27(2):69-86. PubMed ID: 7416444
    [No Abstract] [Full Text] [Related]

  • 20. [Combined immunotherapy and cytostatic therapy in stage II and III malignant melanoma (proceedings)].
    Rundenstam CM.
    Lakartidningen; 1978 Dec 06; 75(49):4568-9. PubMed ID: 723339
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.